An independent 12-month MRI study of Teva’s Copaxone multiple sclerosis treatment has reported significant regeneration of brain tissue of MS sufferers and proves Copaxone’s ability to repair the brain lesions responsible for MS.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000712436